HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis.

AbstractPURPOSE:
To investigate potential associations of the ICAM-1 gene polymorphisms and Fuchs uveitis in a cohort of Italian patients.
METHODS:
Seventy-one consecutive Italian patients affected by Fuchs uveitis were observed at the Ocular Immunology Unit, Arcispedale S. Maria Nuova (Reggio Emilia, Italy) from 2002 to 2008. Two hundred twenty-six healthy Italian blood donors from the same geographic area were selected as the control group. All Fuchs uveitis patients and control subjects were genotyped by polymerase chain reaction (PCR) and allele-specific oligonucleotide techniques for ICAM-1 polymorphisms at codon 241 (exon 4).
RESULTS:
The frequency of the ICAM-1 G/R 241 polymorphism was significantly higher in Fuchs uveitis than in the control subjects (16.9% vs. 5.8%; P=0.006, Pcorr=0.012; odds ratio, 3.3; 95% confidence interval, 1.4-7.7). No significant association between clinical features and ICAM-1 polymorphisms was found.
CONCLUSIONS:
This study demonstrates for the first time that the ICAM-1 G/R 241 polymorphism may represent a candidate gene for Fuchs uveitis susceptibility.
AuthorsLuca Cimino, Luigi Boiardi, Raffaella Aldigeri, Bruno Casali, Davide Nicoli, Enrico Farnetti, Carlo Salvarani, Daniele Cirone, Liberatina De Martino, Alessandro Pupino, Luca Cappuccini
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 51 Issue 9 Pg. 4447-50 (Sep 2010) ISSN: 1552-5783 [Electronic] United States
PMID20445114 (Publication Type: Journal Article)
Chemical References
  • Intercellular Adhesion Molecule-1
Topics
  • Adult
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Heterozygote
  • Humans
  • Intercellular Adhesion Molecule-1 (genetics)
  • Italy
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Uveitis, Anterior (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: